Literature DB >> 12560061

Determination of 5-aminosalicylic acid in pharmaceutical formulation by differential pulse voltammetry.

Biljana Nigović1, Branimir Simunić.   

Abstract

The oxidative behaviour of 5-aminosalicylic acid (5-ASA) has been investigated by differential pulse voltammetry using a glassy carbon electrode in different buffer systems. Linear sweep voltammetry was used to study the influence of pH on the peak current and peak potential. The solution conditions and instrumental parameters were optimized to obtain a good sensitivity. The Britton-Robinson buffer of pH 1.81 was selected as a suitable analytical medium in which 5-ASA exhibited a sensitive diffusion controlled oxidative peak at 0.564 V (vs. Ag/AgCl). The peak current varied linearly with drug concentration in the range between 1 x 10(-4) and 2 x 10(-6) M. The proposed voltammetric method has been applied to the determination of the drug in commercial delayed-release tablet forms. A mean recovery of 101.23% with a relative standard deviation of 1.35% was obtained.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560061     DOI: 10.1016/s0731-7085(02)00469-7

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Reaction of 5-aminosalicylic acid with peroxyl radicals: protection and recovery by ascorbic acid and amino acids.

Authors:  Camilo López-Alarcón; Claudia Rocco; Eduardo Lissi; Catalina Carrasco; J Arturo Squella; Luis Nuñez-Vergara; Hernan Speisky
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

2.  Fabrication of multiwalled carbon nanotube-surfactant modified sensor for the direct determination of toxic drug 4-aminoantipyrine.

Authors:  Jayant I Gowda; Arunkumar T Buddanavar; Sharanappa T Nandibewoor
Journal:  J Pharm Anal       Date:  2015-01-17

3.  A chromatographic approach to development of 5-aminosalicylate/folic acid fixed-dose combinations for treatment of Crohn's disease and ulcerative colitis.

Authors:  Mario-Livio Jeličić; Edvin Brusač; Daniela Amidžić Klarić; Biljana Nigović; Nikša Turk; Ana Mornar
Journal:  Sci Rep       Date:  2020-11-30       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.